Gen-Probe, Roche Win Arbitration against Qiagen | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe said after the close of the market on Wednesday that an arbitration panel has ruled in favor of it and Roche against Qiagen regarding Gen-Probe's supply and purchase agreement with Roche for human papillomavirus products.

San Diego-based Gen-Probe said that a three-member arbitration panel from the International Centre for Dispute Resolution issued an interim award that dismisses all of Qiagen's claims. The firm said that it expects the award to remain unchanged, though it is subject to further proceedings related to its implementation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.